Protecting privacy using k-anonymity K El Emam, FK Dankar Journal of the American Medical Informatics Association 15 (5), 627-637, 2008 | 471 | 2008 |
A globally optimal k-anonymity method for the de-identification of health data K El Emam, FK Dankar, R Issa, E Jonker, D Amyot, E Cogo, JP Corriveau, ... Journal of the American Medical Informatics Association 16 (5), 670-682, 2009 | 353 | 2009 |
Practicing differential privacy in health care: A review. FK Dankar, K El Emam Trans. Data Priv. 6 (1), 35-67, 2013 | 226 | 2013 |
The application of differential privacy to health data FK Dankar, K El Emam Proceedings of the 2012 Joint EDBT/ICDT Workshops, 158-166, 2012 | 146 | 2012 |
Informed consent in biomedical research FK Dankar, M Gergely, SK Dankar Computational and structural biotechnology journal 17, 463-474, 2019 | 134 | 2019 |
Fake it till you make it: Guidelines for effective synthetic data generation FK Dankar, M Ibrahim Applied Sciences 11 (5), 2158, 2021 | 116 | 2021 |
Estimating the re-identification risk of clinical data sets FK Dankar, K El Emam, A Neisa, T Roffey BMC medical informatics and decision making 12, 1-15, 2012 | 115 | 2012 |
A multi-dimensional evaluation of synthetic data generators FK Dankar, MK Ibrahim, L Ismail IEEE Access 10, 11147-11158, 2022 | 77 | 2022 |
Evaluating the risk of re-identification of patients from hospital prescription records K El Emam, FK Dankar, R Vaillancourt, T Roffey, M Lysyk The Canadian journal of hospital pharmacy 62 (4), 307, 2009 | 70 | 2009 |
Dynamic-informed consent: A potential solution for ethical dilemmas in population sequencing initiatives FK Dankar, M Gergely, B Malin, R Badji, SK Dankar, K Shuaib Computational and structural biotechnology journal 18, 913-921, 2020 | 69 | 2020 |
Re-identification risk in de-identified databases containing personal information K El Emam, F Dankar US Patent 8,316,054, 2012 | 68 | 2012 |
A method for evaluating marketer re-identification risk FK Dankar, K El Emam Proceedings of the 2010 EDBT/ICDT Workshops, 1-10, 2010 | 54 | 2010 |
The development of large-scale de-identified biomedical databases in the age of genomics—principles and challenges FK Dankar, A Ptitsyn, SK Dankar Human genomics 12, 1-15, 2018 | 53 | 2018 |
System and method for optimizing the de-identification of data sets K El Emam, I Romeo, F Dankar US Patent 8,326,849, 2012 | 50 | 2012 |
Evaluating the risk of patient re-identification from adverse drug event reports K El Emam, FK Dankar, A Neisa, E Jonker BMC medical informatics and decision making 13, 1-14, 2013 | 40 | 2013 |
De-identifying a public use microdata file from the Canadian national discharge abstract database KE Emam, D Paton, F Dankar, G Koru BMC medical informatics and decision making 11, 1-26, 2011 | 33 | 2011 |
Evaluating the Risk of Re-identification of Patients from Hospital Prescription Records. KE Emam, FK Dankar, R Vaillancourt, T Roffey, M Lysyk The Canadian Journal of Hospital Pharmacy 62 (4), 307-319, 2009 | 33 | 2009 |
Privacy-preserving analysis of distributed biomedical data: designing efficient and secure multiparty computations using distributed statistical learning theory FK Dankar, N Madathil, SK Dankar, S Boughorbel JMIR medical informatics 7 (2), e12702, 2019 | 32 | 2019 |
A protocol for the secure linking of registries for HPV surveillance K El Emam, S Samet, J Hu, L Peyton, C Earle, GC Jayaraman, T Wong, ... PLoS One 7 (7), e39915, 2012 | 32 | 2012 |
A risk-based framework for biomedical data sharing F Dankar, R Badji journal of biomedical informatics 66, 231-240, 2017 | 27 | 2017 |